Journey Medical (DERM) Price to Earnings (2021 - 2026)

Journey Medical (DERM) has reported Price to Earnings for 6 consecutive years, with 623.9 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 1316.21% year-over-year to 623.9; the trailing twelve-month figure through Jun 2026 stood at 53.24 (down 176.26% YoY), and the FY2025 full-year result was 18.15, down 233.31% from the prior year.
• Price to Earnings slipped to 623.9 in Q2 2026 per DERM's latest filing, from 57.43 in the prior quarter.
• Across five years, Price to Earnings topped out at 135.74 in Q4 2025 and bottomed at 623.9 in Q2 2026.
• Historically, Price to Earnings has averaged 47.37 across 5 years, with a median of 20.71 in 2025.
• The widest YoY moves for Price to Earnings: up 203.04% in 2024, down 1715.38% in 2024.
• Over 5 years, Price to Earnings stood at 3.16 in 2022, then sank by 1449.36% to 49.01 in 2023, then surged by 203.04% to 50.5 in 2024, then jumped by 168.81% to 135.74 in 2025, then plunged by 559.62% to 623.9 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 623.9, 57.43, and 135.74 for Q2 2026, Q1 2026, and Q4 2025 respectively.